Premium
Correspondence
Author(s) -
GoihmanYahr Mauricio
Publication year - 1998
Publication title -
international journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 93
eISSN - 1365-4632
pISSN - 0011-9059
DOI - 10.1046/j.1365-4362.1998.00522.x
Subject(s) - clofazimine , dapsone , medicine , dermatology , griseofulvin , isoniazid , erythema , leprosy , pathology , tuberculosis
Erythema dyschromicum perstans: response to dapsone therapy Erythema dyschromicum perstans (EDP), or ashy dermatosis, is a chronic hyperpigmentary skin disorder characterized by ash‐gray macules, often with an active red border. 1 , 2 Various therapies have been tried, including sun protection, chemical peels, antibiotics, corticosteroids, vitamins, isoniazid, griseofulvin, and chloroquine, without any benefit. 1–4 Some authors have suggested the therapeutic efficacy of clofazimine on EDP. 5 We report two cases of EDP which responded remarkably well to treatment with dapsone.